Clinical Trial

An International Survey on the Use of NIV Outside the ICU

Study acronym: NIV-SAFETY
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 30, 2025 (before its estimated March 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
Non-invasive ventilation (NIV) is a way to support breathing using a mask or helmet instead of a breathing tube, and it is proven to reduce the need for intubation, save lives, shorten hospital stays, and lower costs. While NIV has long been used in intensive care units, it is now increasingly applied in emergency rooms, hospital wards, and long-term care facilities. However, global data on how it is used outside ICUs-such as which patients receive it, how well it works, and what barriers exist-is lacking. The NIV-Safety Study is a worldwide survey of doctors, nurses, and respiratory therapists to understand current practices, outcomes, and challenges of NIV use beyond the ICU. The findings aim to guide safer, more effective, and standardized use of NIV across different healthcare settings.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-28.
Status change: Not Yet Recruiting → Recruiting 2025-09-28
Trial Details
NCT Number NCT07157215
Lead Sponsor Dr. Ram Manohar Lohia Hospital
Collaborators: Sanjay Gandhi Postgraduate Institute of Medical Sciences, Hamad Medical Corporation, Instituto Murciano de Investigación Biosanitaria (IMIB)
Conditions Non-invasive Ventilation, Intensive Care (ICU), Safety
Enrollment 400 participants
Start Date 2025-09-16
Primary Completion 2026-03-15 (estimated)
Study Completion 2026-03-15 (estimated)
Updated on ClinicalTrials.gov 2025-09-30